序号 |
标题 |
次数 |
作者 |
发布时间 |
77806 |
p-NO2-Bn-DOTA,CAS:116052-88-1 |
88 |
h |
2024-12-16 |
77807 |
CAS: 1059189-65-9,m-PEG4-CH2-aldehyde |
72 |
WYQ |
2024-12-16 |
77808 |
Azido-mono-amide-DOTA,叠氮基-单-酰胺-DOTA |
76 |
h |
2024-12-16 |
77809 |
cas:297162-47-1,Hydroxy-PEG6-CH2CO2tBu |
67 |
WYQ |
2024-12-16 |
77810 |
cas:1807530-05-7,Hydroxy-PEG5-CH2CO2tBu |
117 |
WYQ |
2024-12-16 |
77811 |
cas:169751-72-8,Hydroxy-PEG4-CH2CO2tBu |
150 |
WYQ |
2024-12-16 |
77812 |
CAS: 518044-31-0,Hydroxy-PEG3-CH2CO2tBu |
80 |
WYQ |
2024-12-16 |
77813 |
CAS: 149299-82-1,Hydroxy-PEG2-CH2CO2tBu |
98 |
WYQ |
2024-12-16 |
77814 |
CAS: 2112737-70-7,m-PEG8-(CH2)12-phosphonic acid ethyl ester |
113 |
WYQ |
2024-12-16 |
77815 |
m-PEG6-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-88-9) |
156 |
WYQ |
2024-12-16 |
77816 |
Butyne-DOTA-tris(t-butyl ester),CAS: 2125661-54-1 |
154 |
h |
2024-12-16 |
77817 |
pAAV-PEG3-sTRAIL质粒 |
98 |
kx |
2024-12-16 |
77818 |
m-PEG4-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-89-0) |
117 |
WYQ |
2024-12-16 |
77819 |
DOTA-PEG4-alkyne,CAS:2080307-47-5 |
80 |
h |
2024-12-16 |
77820 |
m-PEG8-(CH2)12-phosphonic acid(CAS号:2093153-86-5) |
73 |
WYQ |
2024-12-16 |
77821 |
DOTA-NHS-ester,CAS:170908-81-3 |
63 |
h |
2024-12-16 |
77822 |
99Tcm-3PEG4-RGD |
110 |
kx |
2024-12-16 |
77823 |
Azido-PEG5-CH2CO2-t-Bu(CAS号:1448451-72-6) |
68 |
WYQ |
2024-12-16 |
77824 |
DOTA螯合剂DOTA-4AMP,CAS:254444-71-8 |
82 |
h |
2024-12-16 |
77825 |
Azido-PEG4-CH2CO2-t-Bu(CAS号:864681-04-9) |
69 |
WYQ |
2024-12-16 |
77826 |
alkoxyamine-PEG4-biotin ,烷氧基胺-四聚乙二醇-生物素 |
214 |
kx |
2024-12-16 |
77827 |
DOTA-CXCR4-L,DOTA-CXCR4靶向肽 |
113 |
h |
2024-12-16 |
77828 |
DOTA-Tetrazine,DOTA-四嗪 |
78 |
h |
2024-12-16 |
77829 |
Ag~(TS)-S(CH2)_(n-1)CH3// Ga2O3/EGaIn junctions,烷基链定制 |
142 |
wyh |
2024-12-16 |
77830 |
CMP-SA-PEG4-biotin的主要结构组成及功能 |
160 |
kx |
2024-12-16 |
77831 |
DOTA-Tetrazine,DOTA-四嗪 |
89 |
h |
2024-12-16 |
77832 |
Au25(SCH2CH2Ph)18,烷基链定制 |
106 |
wyh |
2024-12-16 |
77833 |
18F-AlF-NOTA-PEG4-ZD2 , 18F-AlF-1,4,7-三氮杂环壬烷-1,4,7-三乙酸-(聚乙二醇)4-ZD2 |
104 |
kx |
2024-12-16 |
77834 |
亲脂性硼剂K[nido-7-CH3(CH2)15-7,8-C2B9H11,烷基链定制 |
79 |
wyh |
2024-12-16 |
77835 |
Azido-PEG3-CH2CO2-t-Bu(CAS号:172531-36-1) |
108 |
WYQ |
2024-12-16 |
77836 |
mPEG113-b-P(MTC-Cholx-co-TMCy)x+y |
107 |
kx |
2024-12-16 |
77837 |
亲脂性硼剂K[nido-7-CH3(CH2)15-7,8-C2B9H11,烷基链定制 |
116 |
wyh |
2024-12-16 |
77838 |
m-PEG6-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-88-9) |
85 |
WYQ |
2024-12-16 |
77839 |
DTPA(Gd)-PEG8-(FY)3 , DTPA(Gd)-聚乙二醇8-(FY)3 |
100 |
kx |
2024-12-16 |
77840 |
靶向CD45的抗体药物偶联物 |
125 |
kx |
2024-12-16 |
77841 |
m-PEG4-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-89-0) |
78 |
WYQ |
2024-12-16 |
77842 |
抗体偶联药物的药物连接子MCMMAF |
109 |
kx |
2024-12-16 |
77843 |
m-PEG8-(CH2)12-phosphonic acid(CAS号:2093153-86-5) |
67 |
WYQ |
2024-12-16 |
77844 |
全氟十四烷酸(PF;CF3(CF2)12COOH),烷基链定制 |
171 |
wyh |
2024-12-16 |
77845 |
靶向CD45的抗体药物偶联物 |
122 |
kx |
2024-12-16 |
77846 |
CH3(CH2)7COOH-CH3(CH2)7COO钠,烷基链定制 |
108 |
wyh |
2024-12-16 |
77847 |
HS(CH2)17CH3 ,十八硫醇,烷基链定制 |
161 |
wyh |
2024-12-16 |
77848 |
Fmoc-Val-Cit-PABC-Cn |
110 |
kx |
2024-12-16 |
77849 |
Mc-Val-Cit-PABOH ,组织蛋白酶B可切割 |
142 |
kx |
2024-12-16 |
77850 |
m-PEG6-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-88-9) |
114 |
WYQ |
2024-12-16 |